GSA Capital Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-17,258
| Closed | -$281K | – | 1914 |
|
|
2022
Q1 | $281K | Sell |
17,258
-4,777
| -22% | -$77.8K | 0.04% | 940 |
|
|
2021
Q4 | $359K | Sell |
22,035
-57,110
| -72% | -$930K | 0.05% | 812 |
|
|
2021
Q3 | $1.18M | Buy |
+79,145
| New | +$1.18M | 0.12% | 230 |
|
|
2019
Q4 | – | Sell |
-7,199
| Closed | -$478K | – | 1806 |
|
|
2019
Q3 | $478K | Buy |
+7,199
| New | +$478K | 0.06% | 583 |
|
|
2017
Q4 | – | Sell |
-12,596
| Closed | -$731K | – | 1884 |
|
|
2017
Q3 | $731K | Buy |
+12,596
| New | +$731K | 0.05% | 714 |
|
|
2015
Q4 | – | Sell |
-4,265
| Closed | -$707K | – | 2016 |
|
|
2015
Q3 | $707K | Buy |
4,265
+3,190
| +297% | +$529K | 0.03% | 897 |
|
|
2015
Q2 | $259K | Buy |
+1,075
| New | +$259K | 0.01% | 1688 |
|
|
2014
Q4 | – | Sell |
-19,412
| Closed | -$4.6M | – | 1946 |
|
|
2014
Q3 | $4.6M | Buy |
19,412
+15,797
| +437% | +$3.74M | 0.24% | 72 |
|
|
2014
Q2 | $855K | Buy |
3,615
+81
| +2% | +$19.2K | 0.04% | 770 |
|
|
2014
Q1 | $1.17M | Buy |
+3,534
| New | +$1.17M | 0.08% | 264 |
|